2012
DOI: 10.1016/j.juro.2012.02.023
|View full text |Cite
|
Sign up to set email alerts
|

Single Center Experience with Endoscopic Subureteral Dextranomer/Hyaluronic Acid Injection as First Line Treatment in 1,551 Children with Intermediate and High Grade Vesicoureteral Reflux

Abstract: Our results confirm the safety and efficacy of the endoscopic injection of dextranomer/hyaluronic acid in the eradication of high grade vesicoureteral reflux. We recommend this 15-minute outpatient procedure as the first line of treatment for high grade vesicoureteral reflux.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
38
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 43 publications
(39 citation statements)
references
References 18 publications
1
38
0
Order By: Relevance
“…It has been a competitive alternative for open surgery, due to its acceptable success rate, safety and simplicity, less time consuming and short length of stay in hospital (12,20). Although the success rate for endoscopic interventions in VUR treatment varies between 70% and 90% in the literature, the optimal technique and bulking agent for STING are controversial (23,24). In addition, it is believed that the advantages of endoscopic intervention provide a possibility to repeat the procedure in case of failure or recurrence (25).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has been a competitive alternative for open surgery, due to its acceptable success rate, safety and simplicity, less time consuming and short length of stay in hospital (12,20). Although the success rate for endoscopic interventions in VUR treatment varies between 70% and 90% in the literature, the optimal technique and bulking agent for STING are controversial (23,24). In addition, it is believed that the advantages of endoscopic intervention provide a possibility to repeat the procedure in case of failure or recurrence (25).…”
Section: Discussionmentioning
confidence: 99%
“…Although many studies suggest that appropriate selection of patients can lead to higher success rate, lower recurrence and complications, however biodegradable agents such as Dx/HA may cause VUR recurrence and failure during long-term follow up (25). The reported success rate is 70% for VUR correction using STING procedure in the literature (8,23). In the current study, the success rate for endoscopic correction of the VUR using Dx/HA injection was 93.3%, which provides a higher rate compared to the literature.…”
Section: Discussionmentioning
confidence: 99%
“…Over the last few decades, endoscopic subureteric injection with bulking agents has gained popularity in the treatment of VUR. Many authors have recommended endoscopic treatment (ET) as the first line of treatment (10)(11)(12)(13)(14)(15).…”
Section: Introductionmentioning
confidence: 99%
“…However, its role in the management of high grade, i.e. grade IV and V reflux still is under debate [1,2,3,4]. A limited number of reports regarding results and efficacy of endoscopic management of high grade reflux is still available.…”
Section: Introductionmentioning
confidence: 99%
“…A limited number of reports regarding results and efficacy of endoscopic management of high grade reflux is still available. Various bulking agents were used for this purpose: polytetrafluoroethylene (PTFE) before 2000, dextranomer/hyaluronic acid copolymer (Dx/HA, Deflux ®) since 2000 and recently polyacrylate-polyalcoholcopolymer (PPC, Vantris ®) [4,5,6,7,8,9,10,11,12]. PPC (Vantris ®) a synthetic, non-absorbable tissueaugmenting substance was introduced into clinical practice in 2010 [13] and is currently used in some centers Around the world [14,15,16,17,18,19,20].The aim of the present study was to evaluate the efficacy of PPC injection to correct reflux grade IV and V in children.…”
Section: Introductionmentioning
confidence: 99%